Legal Status Overview
Gray AreaNorth Carolina has no statute or Board of Pharmacy rule that uses the terms "peptide" or "research chemical" as a defined legal category, so peptide products default to general pharmacy, compounding, and controlled-substance law rather than a peptide-specific regime. The North Carolina Controlled Substances Act does, however, name one peptide hormone specifically: chorionic gonadotropin (hCG) is listed as a Schedule III "anabolic steroid" substance, meaning it is a prescription-only controlled substance in the state. Other widely discussed peptides (BPC-157, TB-500, GLP-1 analogs like semaglutide/tirzepatide, growth-hormone secretagogues) are unscheduled in North Carolina and are instead governed by the North Carolina Board of Pharmacy's compounding rules, which track the federal 503A/503B framework and FDA's drug-approval and "essentially a copy" restrictions. No North Carolina-specific bill, Board of Pharmacy bulletin, or Attorney General guidance uniquely targeting peptides or research chemicals was found as of this review.
Key Points
- North Carolina's Controlled Substances Act (G.S. Chapter 90, Article 5) does not define or list "peptides" or "research chemicals" as a distinct legal category anywhere in its text. [2]
- North Carolina law specifically names the peptide hormone chorionic gonadotropin (hCG) as a Schedule III controlled "anabolic steroid," so dispensing or distributing it without a prescription from a registered pharmacist is a controlled-substance offense in the state. [3]
- The North Carolina Pharmacy Practice Act defines "compounding" generally as combining two or more ingredients into a drug dosage form, and the North Carolina Board of Pharmacy applies this same general compounding framework to peptide-containing preparations rather than a peptide-specific rule. [4]
- The North Carolina Board of Pharmacy follows the federal Food, Drug & Cosmetic Act's rule that pharmacies generally cannot compound drug products that are "essentially copies" of a commercially available drug, which limits routine compounding of GLP-1 products like semaglutide and tirzepatide outside of specific shortage-based exceptions. [1]
- FDA set deadlines of April 22, 2025 for state-licensed 503A compounding pharmacies and May 22, 2025 for 503B outsourcing facilities to stop relying on the semaglutide/tirzepatide drug-shortage exception, a timeline the North Carolina Board of Pharmacy has published directly to licensees. [1]
- A person cannot lawfully bring or buy hCG into North Carolina without a valid prescription because it is classified as a Schedule III controlled substance there, while unscheduled research peptides like BPC-157 and TB-500 are not criminalized under North Carolina's controlled-substances schedules but remain unapproved by the FDA for human use, which is a federal rather than a state-specific restriction. [3]
- The legally sanctioned pathway to obtain peptide medications in North Carolina is a valid prescription from a licensed practitioner filled by a North Carolina-licensed pharmacy or a 503A/503B compounder operating under the Board of Pharmacy's rules, not direct retail or online purchase of unapproved research-labeled material. [4]
- No North Carolina-specific peptide or "research chemical" bill, enforcement action, or Attorney General consumer alert from the last 2-3 years was located in this review; searches of the NC General Assembly bill tracker and Board of Pharmacy materials returned only general compounding and unrelated legislation. (No reliable source found for this point — flagged as unverified rather than stated as fact.)
Peptide-by-peptide status in North Carolina
| BPC-157 | BPC-157 is not separately scheduled or named in any North Carolina statute or Board of Pharmacy rule, so its legal status in North Carolina is governed entirely by the general federal FDA framework, under which it remains an unapproved drug not lawfully marketed for human use. [2] |
|---|---|
| Semaglutide / Tirzepatide (GLP-1 class) | Branded semaglutide and tirzepatide are legal, prescription-only medicines in North Carolina, but North Carolina-licensed compounding pharmacies may only legally produce compounded copies under narrow 503A/503B exceptions that the FDA largely closed off by April-May 2025 once the national shortage ended. [1] |
| TB-500 | Like BPC-157, TB-500 has no North Carolina-specific statute or Board of Pharmacy rule naming it, so its status in North Carolina defaults to the same federal "unapproved drug not for human use" research-chemical framework rather than any state-specific scheduling. [2] |
| Human Growth Hormone (HGH/somatropin) | Somatropin/HGH is legal in North Carolina only as a prescription medication for a diagnosed condition such as growth hormone deficiency, as reflected in NC Medicaid's prior-authorization criteria requiring documented hormone-deficiency testing before coverage is approved. [5] |
| Chorionic gonadotropin (hCG) | hCG is explicitly classified as a Schedule III controlled "anabolic steroid" substance under North Carolina's Controlled Substances Act, making it the one peptide hormone North Carolina regulates by name and requiring a valid prescription for lawful human use. [3] |
Sources
Last researched: 2026-10-02
Frequently asked questions
Can I buy BPC-157 or other research peptides in North Carolina without a prescription?
North Carolina has no state law that specifically bans or schedules BPC-157, so purchases of "research use only" peptides are not blocked by a distinct North Carolina statute, but they remain unapproved drugs under federal FDA law and cannot be lawfully marketed or sold for human consumption regardless of state. [2]
Is compounded semaglutide or tirzepatide still legal to get in North Carolina?
Compounded semaglutide and tirzepatide are only legal in North Carolina when prescribed and dispensed through a licensed pharmacy or outsourcing facility operating within the narrow 503A/503B drug-shortage exceptions, and the North Carolina Board of Pharmacy has flagged that FDA ended those shortage-based allowances by April 22, 2025 (503A) and May 22, 2025 (503B). [1]
Is HGH legal to use in North Carolina?
HGH (somatropin) is legal in North Carolina only when prescribed by a licensed practitioner for an approved medical indication such as documented growth hormone deficiency; North Carolina Medicaid's own coverage policy requires biochemical proof of deficiency before authorizing it. [5]
What are the penalties for possessing hCG or peptide hormones without a prescription in North Carolina?
Because North Carolina's Controlled Substances Act classifies chorionic gonadotropin (hCG) as a Schedule III anabolic steroid, possessing or distributing it without a valid prescription from a registered pharmacist can expose a person to the same state criminal penalties that apply to other Schedule III controlled substances. [3]
Has North Carolina passed any new peptide-specific legislation recently?
No North Carolina-specific peptide or research-chemical bill has been identified as of this review; the state continues to rely on its general Pharmacy Practice Act, Board of Pharmacy compounding rules, and Controlled Substances Act rather than any new peptide-targeted statute.